CMN Financial Facts
Total operating expenses: 62.44MResearch and development: 4.55M
See Full Income Statement
Prepaid expenses and other current assets: 12.41M
Deferred revenue: 20.62M
See Full Balance Sheet
Cantel Medical (CMN) Earnings
|
Expand Research on CMN
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +27.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +2.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
9/29/16  |
 |
Q416 | $0.48 | $0.37 | +$0.11 | $179M | $178.58M | N/A |  | | Details |
| 6/8/16 |
|
Q316 | $0.44 | $0.36 | +$0.08 | $173.7M | $163.16M | N/A | | | Details |
| 3/10/16 |
|
Q216 | $0.43 | $0.34 | +$0.09 | $158.3M | $154.51M | N/A | | | Details |
| 12/10/15 |
Q116 | $0.41 | $0.31 | +$0.10 | $153.8M | $154.62M | N/A | | | Details | |
| 9/29/15 |
|
Q415 | $0.39 | $0.31 | +$0.08 | $151.26M | $145.2M | N/A | | | Details |
| 6/9/15 |
Q315 | $0.35 | $0.29 | +$0.06 | $120.06M | $135.95M | N/A | | | Details | |
| 3/12/15 | Q215 | $0.26 | $0.28 | -$0.02 | $135.4M | $142.6M | N/A | | | Details | |
| 12/10/14 |
|
Q115 | $0.34 | $0.28 | +$0.06 | $136.81M | $141.51M | N/A | | | Details |
